寶鼎科技(002552.SZ):公司控股股東將由招金集團變更為金都國投,實控人仍是招遠市人民政府
格隆匯6月12日丨寶鼎科技(002552.SZ)公佈,2023年6月11日,公司控股股東山東招金集團有限公司(“招金集團”)與山東金都國有資本投資集團有限公司(“金都國投”)簽署《關於寶鼎科技股份有限公司之股份轉讓協議》,招金集團擬通過非公開協議轉讓方式,以18.2元/股的價格向金都國投轉讓所持有的上市公司116,062,100股股份,占上市公司總股本的26.6435%。
此次股份轉讓完成後,公司控股股東將由招金集團變更為金都國投,公司實際控制人仍是招遠市人民政府。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.